ACACA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.693820E-01
Normal-vs-Stage2
3.259000E-01
Normal-vs-Stage3
5.930200E-01
Normal-vs-Stage4
2.221000E-01
Stage1-vs-Stage2
3.692600E-01
Stage1-vs-Stage3
5.762400E-01
Stage1-vs-Stage4
4.206000E-01
Stage2-vs-Stage3
8.991200E-01
Stage2-vs-Stage4
8.885000E-01
Stage3-vs-Stage4
9.943400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.934000E-01
Normal-vs-AfricanAmerican
4.001400E-01
Normal-vs-Asian
3.353600E-01
Caucasian-vs-AfricanAmerican
6.981800E-01
Caucasian-vs-Asian
6.090400E-01
AfricanAmerican-vs-Asian
9.985600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.593600E-01
Normal-vs-Female
2.251600E-01
Male-vs-Female
2.334600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.495750E-01
Normal-vs-Age(41-60Yrs)
1.307620E-01
Normal-vs-Age(61-80Yrs)
4.058200E-01
Normal-vs-Age(81-100Yrs)
3.217600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.285200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.676400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.360990E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.492000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.336190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.685800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.469600E-01
Normal-vs-Daily Drinker
5.492600E-01
Normal-vs-Weekly Drinker
4.035800E-01
Normal-vs-Occasional Drinker
1.645610E-01
Normal-vs-Social Drinker
3.279900E-02
Non Drinker-vs-Daily Drinker
8.937200E-01
Non Drinker-vs-Weekly Drinker
9.079000E-01
Non Drinker-vs-Occasional Drinker
9.183600E-02
Non Drinker-vs-Social Drinker
3.941900E-02
Daily Drinker-vs-Weekly Drinker
8.340000E-01
Daily Drinker-vs-Occasional Drinker
1.162440E-01
Daily Drinker-vs-Social Drinker
5.704100E-02
Weekly Drinker-vs-Occasional Drinker
1.905040E-01
Weekly Drinker-vs-Social Drinker
7.403900E-02
Occasional Drinker-vs-Social Drinker
8.318200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.836030E-01
Normal-vs-Grade 2
7.722100E-02
Normal-vs-Grade 3
6.120000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.481200E-01
Grade 1-vs-Grade 3
5.512200E-01
Grade 1-vs-Grade 4
1.836030E-01
Grade 2-vs-Grade 3
3.939600E-01
Grade 2-vs-Grade 4
7.722100E-02
Grade 3-vs-Grade 4
6.120000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.420200E-01
Normal-vs-NonDiabetic
1.819230E-01
Diabetic-vs-NonDiabetic
1.852340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.004830E-01
Normal-vs-NoPancreatitis
3.194600E-01
Pancreatitis-vs-NoPancreatitis
1.327010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.765800E-01
Normal-vs-N1
3.585200E-01
N0-vs-N1
4.184600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.194760E-01
Normal-vs-TP53-NonMutant
2.864400E-01
TP53-Mutant-vs-TP53-NonMutant
8.525600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
